» Authors » Thorsten C W Wahlers

Thorsten C W Wahlers

Explore the profile of Thorsten C W Wahlers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 90
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Eghbalzadeh K, Grossmann C, Krasivskyi I, Djordjevic I, Kuhn E, Origel Romero C, et al.
Thorac Cardiovasc Surg . 2024 Aug; PMID: 39134038
Background:  Ventricular septal defects (VSDs) remain a rare but life-threatening complication of myocardial infarction. Although the incidence has decreased due to better treatment options, the mortality rate remains high. The...
2.
Eghbalzadeh K, Wahlers T, Deppe A
Thorac Cardiovasc Surg . 2023 Jul; 72(4):296-299. PMID: 37463601
Background:  Surgically implanted Impella 5.5. delivers full cardiac support and left ventricular unloading for patients with heart failure. So far, the Impella device is implanted under general anesthesia (GA). Material...
3.
Gerfer S, Kuhn E, Gablac H, Ivanov B, Djordjevic I, Mauri V, et al.
Thorac Cardiovasc Surg . 2022 Jul; 71(2):101-106. PMID: 35853463
Background: Transcatheter aortic valve replacement (TAVR) has become an established alternative to surgical aortic valve replacement (AVR) for higher risk patients. Periprocedural TAVR complications decreased with a growing expertise of...
4.
Eghbalzadeh K, Kuhn E, Gerfer S, Djordjevic I, Rahmanian P, Mader N, et al.
Thorac Cardiovasc Surg . 2022 Jun; 72(3):167-172. PMID: 35667381
Background:  For patients undergoing aortic valve replacement (AVR), structural valve deterioration (SVD) of a bioprosthesis (BP) is substantially accelerated in younger patients and valve-in-valve implantation is not always a considerable...
5.
Gerfer S, Grandoch M, Wahlers T, Kuhn E
Thorac Cardiovasc Surg . 2021 Dec; 71(3):189-194. PMID: 34894638
Patients with a mechanical heart valve need a lifelong anticoagulation due to the increased risk of valve thrombosis and thrombo-embolism. Currently, vitamin K antagonists (VKA) are the only approved class...
6.
Schlachtenberger G, Deppe A, Gerfer S, Choi Y, Zeriouh M, Liakopoulos O, et al.
Thorac Cardiovasc Surg . 2020 Jun; 68(8):714-722. PMID: 32593177
Objective: Patients with acute coronary syndrome are treated with dual antiplatelet therapy containing acetylsalicylic acid (ASA) and P2Y12 antagonists. In case of urgent coronary artery bypass grafting this might be...
7.
Kuhn E, Liakopoulos O, Choi Y, Rahmanian P, Eghbalzadeh K, Slottosch I, et al.
Thorac Cardiovasc Surg . 2020 Jun; 69(2):141-147. PMID: 32506416
Background: Performing cardiac surgery in patients with cardiovascular risk factors incorporates a steady risk for the development of postoperative complications. Perioperative statin intake was associated with an improvement of perioperative...
8.
Mauri V, Frohn T, Deuschl F, Mohemed K, Kuhr K, Reimann A, et al.
Open Heart . 2020 May; 7(1). PMID: 32393655
Objective: Residual paravalvular regurgitation (PVR) has been associated to adverse outcomes after transcatheter aortic valve replacement (TAVR). This study sought to evaluate the impact of device landing zone (DLZ) calcification...
9.
Gaisendrees C, Eghbalzadeh K, Mader N, Wahlers T
Thorac Cardiovasc Surg Rep . 2019 Dec; 8(1):e41-e43. PMID: 31871853
Primary malignant tumors of the heart are rare; the biggest group is sarcomas. Cardiac metastases make up the biggest group of secondary cardiac tumors. We present a rare case of...
10.
Weber C, Esser M, Eghbalzadeh K, Sabashnikov A, Djordjevic I, Maier J, et al.
Thorac Cardiovasc Surg . 2019 Nov; 68(5):401-409. PMID: 31770777
Background: There has been conflicting evidence concerning the effect of levosimendan on clinical outcomes in patients undergoing cardiac surgery. Therefore, we performed a systematic review and conducted this meta-analysis to...